Epidemiology of human papillomavirus infection in Ukraine

Authors

  • А. А. Суханова National Medical Academy of Postgraduate Education named after P.L. Shupyk, Ukraine
  • Г. И. Сиротинская Medical laboratory «DILA», Ukraine
  • М. Н. Шалько National Medical Academy of Postgraduate Education named after P.L. Shupyk, Ukraine
  • О. И. Гервазюк National Medical Academy of Postgraduate Education named after P.L. Shupyk, Ukraine
  • Е. В. Сидоренко Medical laboratory «DILA», Ukraine
  • И. М. Лозянко Medical laboratory «DILA», Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2014.19.68-77

Keywords:

human papillomavirus, cervical intraepithelial neoplasia, reproductive age, region

Abstract

In this paper, the presented results of statistical data processing of pathological changes in the epithelium of the cervix associated with human papillomavirus (HPV) infection in Ukraine and in the world, depending on the type of pathogen, age, place of residence.

In particular, in Ukraine it was established:

• the level of newly diagnosed high oncogenic genotypes of HPV higher than the level of low oncogenic genotypes;

• confi rmed the highest prevalence of HPV type 16 in various cities of Ukraine, regardless of age; second place is occupied 31, 33, 53, 68 HPV genotypes;

• in women younger than 25 years it is the highest prevalence of HPV high oncogenic genotypes (52%); there is an inverse correlation between the prevalence of HPV high oncogenic genotypes depending on age

Author Biographies

А. А. Суханова, National Medical Academy of Postgraduate Education named after P.L. Shupyk

PhD, associate professor of the Obstetrics, Gynecology and Reproduction Department

Г. И. Сиротинская, Medical laboratory «DILA»

Кандидат медицинских наук

М. Н. Шалько, National Medical Academy of Postgraduate Education named after P.L. Shupyk

Obstetrics, Gynecology and Reproduction Department

О. И. Гервазюк, National Medical Academy of Postgraduate Education named after P.L. Shupyk

Obstetrics, Gynecology and Reproduction Department

Е. В. Сидоренко, Medical laboratory «DILA»

Кандидат медицинских наук

References

  1. «Human papillomavirus infection // Introduction of HPV vaccines in European Union countries.» – an update (2012).
  2. Laia Bruni, Mireia Diaz, Xavier Castellsague «Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings.» J. Infect Dis., 202(15 December) (2010):1790.
  3. Inoue M., Sakaguchi J., Sasagawa T., Tango M. International Journal of Gynecological Cancer, 16, I. 3(2006):1007-1013.
  4. Pina-Sanchez P., Hernandez-Hernandez D.M., Lopez-Romero R. et al. International Journal of Gynecological Cancer, 16, I. 3(2006):1041-1047.
  5. Cutts F.T., Franceschi S., GoldieS. «Human papillomavirus and HPV vaccines: a review.» Bulletin of the World Health Organization (2009).
  6. William Atkinson, Charles (Skip) Wolfe, Jennifer Hamborsky «Human Papillomavirus.» Epidemiology and Prevention of Vaccine-Preventable Diseases [The Pink Book: Course Textbook]. – 12th Edition Second Printing( 2012).
  7. Adapted from Parkin D.M.& Bray F. Vaccine, 24(Suppl 3) (2006):11-25.
  8. Walboomers J. M. et al. Pathol, 189(1999):12-19.
  9. William Atkinson, Charles (Skip) Wolfe, Jennifer Hamborsky «Human Papillomavirus.» Epidemiology and Prevention of Vaccine-Preventable Diseases. – 12th Edition Second Printing (2012).
  10. Ashrafyan L.A., Kiselev V.I. «Tumors of the reproductive organs (etiology and pathogenesis).» M: Dimitreyd Schedule Group (2008):216.
  11. Podzolkova N.M., Rogovskaya S.I., Fadeev I.E., Ardus F.S. «HPV infection: what’s new?» Gynecology, 13(5) (2011):39-45.
  12. Evtina I.P., Sidorova I.S., Hunanian A.L., Vlasov R.S., Kadyrova A.E., Karpov D.V. «Current aspects of the pathogenesis of benign and precancerous cervical disease (literature review).» Biomedical Journal, 12(2011):431-447.
  13. Chaklin A.V. «Century problem (Oncology: search and decision).» M. (2008):144 p.
  14. Cornelissen M.T., Bots Т., Briet M.A. et al. «Detection of human papillomavirus types by the polymerase chain reaction and the diff erentiation between high-risk and low-risk cervical lesions.» Virchows Arch. В Cell Pathol. Incl. Mol. Pathol, 62(3) (1992):167-171.
  15. Cecchini S., Lossa A., Ciatto S. et al. «Routine colposcopic survey of patients with squamous atypia. A method for identifying cases with false-negative smears.» Acta Cytol, 34(6) (1990):778-780.
  16. Eileen M. Burd «Human Papillomavirus and Cervical Cancer.» Clin Microbiol, Jun. 16(1) (2003):1-17.
  17. Podilchak M.D. «Chronic infl ammation and tumor growth.» K. (2011):180 p.
  18. Prilepskaya V.N. «Age characteristics of the cervix. Modern methods of diagnosis of cervical pathology.» Obstetrics and Gynecology, 6(1998):51-54.
  19. Dotsenko Y.S. «Dysplasia is not a cancer, but it should treat immediately.» Let’s be Healthy, 5(2001):14-15.
  20. Cinel A., Oselladore M., Insacco E., Minucci D. «The accuracy of colposcopically directed biopsy in the diagnosis of cervical intraepithelial neoplasia.» Eur. J. Gynaecol. Oncol., 1(6) (1990):433-437.
  21. Schalko M.N. «Diagnosis, pathogenesis and treatment of precancerous processes of glandular epithelium of the cervix in women with tubal-peritoneal factor infertility: Thesis for PhD on specialty 14.01.01 «Obstetrics and Gynecology». Kyiv (2013):19 p.
  22. Kaunov L.A. «Effi cacy of treatment of pathological conditions of cervical with cryosurgical method depending on the age and immune characteristics of women: Author. Thesis for PhD on specialty 14.01.01 «Obstetrics and Gynecology.» Ivanovo (1988):24 p.
  23. Rose B.R., Thompson C. H., Simpson J. M. et al. «Human papyomavirus deoxyribonucleic acid as a prognostic indicator in earlystage cervical cancer: a possible role for type 18.» Am. J. Obstet. Gynecol, 173(5) (1995):1461-1468.
  24. Susanne K. Kjеr, Kirsten Frederiksen, Christian Munk and Thomas Iftner «Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence.» J Natl Cancer Inst, 102(19) (2010):1478-1488. October 6.
  25. Suchich G.N., Prilepskaya V.N. «Prevention of Cervical Cancer: Guideline for Physicians.» 3rd ed. Revised and additional. - M: MEDpress-inform (2012):192 p.
  26. Sukhanova A.A. «Current views on the role of infectious factors in the occurrence and development of cervical dysplasia.» Bulletin of the Association of Obstetricians and Gynecologists of Ukraine, 3(1999):9-14.
  27. Sukhanova A.A. «Pathogenesis, prevention, diagnostics and treatment of background and precancerous cervix process in pregnancy: Thesis for PhD on specialty. 14.01.01 «Obstetrics and Gynecology», Kyiv (2010):35 p.
  28. Wisniewski A.S., Safronnikova N.R. «Controversial issues of treatment of human papillomavirus infection of the cervix.» Practical Oncology, 3(3) (2002):166-172.
  29. Glick B., Pasternak J. «Molecular Biotechnology. Principles and applications.» M. (2002):349-368.
  30. Dubinsky V.V. «Urogenital HPV infection (literature review).» Russian Journal of Skin and Venereal Diseases, 5(2000):50-55.
  31. Evstigneeva N.P. «Human papillomavirus infection of the urogenital tract of women: epidemiology, persistence factors, optimization of early diagnosis and prevention of carcinogenesis: Thesis for MD.» Moscow (2007):42 p.
  32. Kiselev F.L. «Genetic and epigenetic factors of progression of cervix tumors.» Bulletin of the Russian Academy of Medical Sciences, 11(2007):25-32.
  33. Kiselev F.L., Mazurenko N.N., Kiseleva N.F. et al. «Molecular markers of cervical cancer.» Journal of Medical Sciences, № 1(2002):8-14.
  34. Kulakov V.I. et al. «Current approaches to the diagnosis of human papillomavirus infection of the genitals in women and their importance for cervical cancer screening.» Gynecology, 2(2000):4-8.
  35. Bashmakova M.A., Savicheva A.M. «HPV infection (Manual for doctors).» Moscow (2003).
  36. Molchanov D. «Human papillomavirus and cervical cancer: a unique relationship and a challenge to modern medicine .» Health of Ukraine, 1(2007):3.
  37. Novick V.I. «Epidemiology of cervical cancer, risk factors, screening.» Practical Oncology, 3(3) (2002):156-162.
  38. Rogovskaya S.I. «Human papillomavirus infection of the lower parts of the genitalia, clinic, diagnostics, treatment. Dis. ... for MD.» M. (2003).
  39. Chernenko V., Mazurenko N.et al. «Deletion mapping using quantitative real–time PCR identifi es two distinct 3p21.3 regions aff ected in most cervical carcinomas.» Oncogene, 22(2003):2984-2992.
  40. Munoz N., Bosch F. X., de Sanjose S., Herrero R., Castellsague X., Shah K. V. et al. «Epidemiologic classifi cation of human papillomavirus types associated with cervical cancer.» N Engl. J. Med, 348(2003):518-52.
  41. GLOBOCAN database. – http : // www–dep.iarc.fr / last access 25.01.2007.
  42. Globocan. Cancer incidence, mortality and prevalence world wide. Last access 25.01.2007. IARC WHU Press Release 151 IARC confi rms effi cacy of cervix cancer screening for women 25–65 in reducing mortality, 03 May, 2004.
  43. Smith J.S., Lindsay L., Hoots B. еt al. «Human papillomavirus type distribution in invasiveе cancer and high–grade cervical lesions : A meta–analysis update .» Int. J Cancer, 121(2007):621-632.
  44. Zur Hauzen H. «Papillomavirus and cancer: from basic studies to clinical application.» Nar. Rev. Cancer, 2(2002):342-350.

Downloads

Published

2014-10-20

How to Cite

Суханова, А. А., Сиротинская, Г. И., Шалько, М. Н., Гервазюк, О. И., Сидоренко, Е. В., & Лозянко, И. М. (2014). Epidemiology of human papillomavirus infection in Ukraine. REPRODUCTIVE ENDOCRINOLOGY, (19), 68–77. https://doi.org/10.18370/2309-4117.2014.19.68-77

Issue

No. 19 (2014)

Section

Tumors and pretumoral pathology

License

Copyright (c) 2015 А. А. Суханова, Г. И. Сиротинская, М. Н. Шалько, О. И. Гервазюк, Е. В. Сидоренко, И. М. Лозянко

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.